| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 8,632,294 | 8,261,623 | 6,857,511 | | Cost of Revenue | 1,915,656 | 1,934,118 | 1,696,545 | | | Gross Profit | 6,716,638 | 6,327,505 | 5,160,966 | | | Operating Expenses | | Research Development | 1,427,125 | 1,424,568 | 1,117,932 | | Selling General and Administrative | 2,944,830 | 2,938,603 | 2,424,900 | | Non Recurring |
-
| 261,688 | 54,693 | | Others |
-
| (63,398) |
-
| | | | Total Operating Expenses |
-
| 4,561,460 |
-
| | | | Operating Income or Loss | 2,344,684 | 1,766,045 | 1,563,441 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 131,134 | 464,718 | 131,865 | | Earnings Before Interest And Taxes | 2,452,320 | 2,230,763 | 1,695,306 | | Interest Expense | 46,617 | 63,990 | 52,392 | | Income Before Tax | 2,405,703 | 2,166,773 | 1,642,914 | | Income Tax Expense | 577,975 | 483,678 | 480,024 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,827,728 | 1,683,095 | 1,116,870 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,827,728 | 1,683,095 | 1,116,870 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,827,728 | $1,683,095 | $1,116,870 |
|
0.29% Nasdaq 
Income Statement
